Abstract:Spliceosomopathies, which are a group of disorders caused by defects in the splicing machinery, frequently affect the craniofacial skeleton and limb, but the molecular mechanism underlying this tissue-specific sensitivity remains unclear. Splicing factors and small nuclear ribonucleoproteins (snRNPs) are core components of splicing machinery, and splicing factors are further controlled by post-translational modifications, among which arginine methylation is one of the most frequent modifications. To determine the splicing mechanisms in cranial neural crest cells (CNCCs), which give rise to the majority of craniofacial skeleton, we focused on upstream regulators for splicing proteins responsible for arginine methylation, protein arginine methyltransferases (PRMT). These enzymes catalyze arginine methylation of splicing factors to modify splicing factor expression and activity, influencing the splicing product. PRMT1 is the highest expressing enzyme of the PRMT family in CNCCs and its role in craniofacial development is evident based on our earlier investigation, where CNCC-specific Prmt1 deletion caused cleft palate and mandibular hypoplasia. In the present study, we uncover roles of PRMT1 in CNCCs in the regulation of intron retention, a type of alternative splicing where introns are retained in the mature mRNA sequence. Mandibular primordium of Prmt1-deficient embryos demonstrated an increase in the percentage of intron-retaining mRNA of matrix genes, which triggered NMD, causing a reduction in matrix transcript expression. We further identified SFPQ as a substrate of PRMT1 that depends on PRMT1 for arginine methylation and protein expression in the developing craniofacial structures. Depletion of SFPQ in CNCCs phenocopied PRMT1 deletion in that matrix, Wnt signaling components and neuronal gene transcripts contained higher IR and exhibited lower expression. We further recognized gene length as a common feature among SFPQ-regulated genes in CNCCs. Altogether, these findings demonstrate that the PRMT1-SFPQ pathway modulates matrix Wnt signaling components and neuronal gene expression via intron retention in CNCCs during craniofacial development.

PRMT1-SFPQ regulates intron retention to control matrix gene expression during craniofacial development

Identification and Characterization of a Novel Gene, Mcpr1, and Its Possible Function in the Proliferation of Embryonic Palatal Mesenchymal Cells

Prmt1 Regulates Craniofacial Bone Formation Upstream of Msx1

Cingulate Protein Arginine Methyltransferases 1 Regulates Peripheral Hypersensitivity Via Fragile X Messenger Ribonucleoprotein

Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing

Expression of A Novel Splice Variant of Frmd7 in Developing Human Fetal Brains That is Upregulated Upon the Differentiation of Nt2 Cells

PDGFRα signaling regulates Srsf3 transcript binding to affect PI3K signaling and endosomal trafficking

SRSF10 Regulates Proliferation of Neural Progenitor Cells and Affects Neurogenesis in Developing Mouse Neocortex.

Loss of MMP9 Disturbs Cranial Suture Fusion Via Suppressing Cell Proliferation, Chondrogenesis and Osteogenesis in Mice

Disease modeling of core pre-mRNA splicing factor haploinsufficiency

The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing

The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis

CSNK1a1 Regulates PRMT1 to Maintain the Progenitor State in Self-Renewing Somatic Tissue

Temporal and tissue specific regulation of RP-associated splicing factor genes PRPF3, PRPF31 and PRPC8--implications in the pathogenesis of RP

HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.

HnRNPR strongly represses splicing of a critical exon associated with spinal muscular atrophy through binding to an exonic AU-rich element

Recruitment Of The Nineteen Complex To The Activated Spliceosome Requires Atprmt5

Glycosylation of DMP1 Maintains Cranial Sutures in Mice.

Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells

Transferrin receptor facilitates TGF- β and BMP signaling activation to control craniofacial morphogenesis

Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation